Global and Japan End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2026

Global and Japan End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 End-Stage Renal Disease (ESRD) Drugs Product Introduction
1.2 Market Segments
1.3 Key End-Stage Renal Disease (ESRD) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type
1.4.2 Calcium Succinate
1.4.3 Mk-3866
1.4.4 Pacritinib
1.4.5 Sanguinate
1.4.6 Tesidolumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 ICU
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue 2015-2026
2.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales 2015-2026
2.2 Global End-Stage Renal Disease (ESRD) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 End-Stage Renal Disease (ESRD) Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global End-Stage Renal Disease (ESRD) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global End-Stage Renal Disease (ESRD) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 End-Stage Renal Disease (ESRD) Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Region (2021-2026)
3 Global End-Stage Renal Disease (ESRD) Drugs Competitor Landscape by Players
3.1 Global Top End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
3.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global End-Stage Renal Disease (ESRD) Drugs Manufacturers by Revenue
3.2.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global End-Stage Renal Disease (ESRD) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by End-Stage Renal Disease (ESRD) Drugs Revenue in 2019
3.2.5 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Manufacturers
3.4 Global End-Stage Renal Disease (ESRD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 End-Stage Renal Disease (ESRD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Type (2015-2020)
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2015-2020)
4.1.3 End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application (2015-2020)
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2015-2020)
5.1.3 End-Stage Renal Disease (ESRD) Drugs Price by Application (2015-2020)
5.2 End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales YoY Growth 2015-2026
6.1.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan End-Stage Renal Disease (ESRD) Drugs Market Share in Global Market 2015-2026
6.2 Japan End-Stage Renal Disease (ESRD) Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top End-Stage Renal Disease (ESRD) Drugs Players by Sales (2015-2020)
6.2.2 Japan Top End-Stage Renal Disease (ESRD) Drugs Players by Revenue (2015-2020)
6.3 Japan End-Stage Renal Disease (ESRD) Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan End-Stage Renal Disease (ESRD) Drugs Price by Type (2015-2020)
6.4 Japan End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2021-2026)
6.5 Japan End-Stage Renal Disease (ESRD) Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan End-Stage Renal Disease (ESRD) Drugs Price by Application (2015-2020)
6.6 Japan End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
7.2 North America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Country
7.2.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020)
7.2.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
8.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Country
8.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country
8.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
10.2 Latin America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Country
10.2.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country
10.2.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country
11.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 CTI BioPharma Corp
12.1.1 CTI BioPharma Corp Corporation Information
12.1.2 CTI BioPharma Corp Description and Business Overview
12.1.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
12.1.5 CTI BioPharma Corp Recent Development
12.2 Merck & Co Inc
12.2.1 Merck & Co Inc Corporation Information
12.2.2 Merck & Co Inc Description and Business Overview
12.2.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Products Offered
12.2.5 Merck & Co Inc Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Description and Business Overview
12.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Products Offered
12.3.5 Novartis AG Recent Development
12.4 Prolong Pharmaceuticals LLC
12.4.1 Prolong Pharmaceuticals LLC Corporation Information
12.4.2 Prolong Pharmaceuticals LLC Description and Business Overview
12.4.3 Prolong Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Products Offered
12.4.5 Prolong Pharmaceuticals LLC Recent Development
12.5 VESSL Therapeutics Ltd
12.5.1 VESSL Therapeutics Ltd Corporation Information
12.5.2 VESSL Therapeutics Ltd Description and Business Overview
12.5.3 VESSL Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
12.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Products Offered
12.5.5 VESSL Therapeutics Ltd Recent Development
12.11 CTI BioPharma Corp
12.11.1 CTI BioPharma Corp Corporation Information
12.11.2 CTI BioPharma Corp Description and Business Overview
12.11.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
12.11.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
12.11.5 CTI BioPharma Corp Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key End-Stage Renal Disease (ESRD) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 End-Stage Renal Disease (ESRD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. End-Stage Renal Disease (ESRD) Drugs Market Segments
Table 2. Ranking of Global Top End-Stage Renal Disease (ESRD) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Calcium Succinate
Table 5. Major Manufacturers of Mk-3866
Table 6. Major Manufacturers of Pacritinib
Table 7. Major Manufacturers of Sanguinate
Table 8. Major Manufacturers of Tesidolumab
Table 9. Major Manufacturers of Others
Table 10. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global End-Stage Renal Disease (ESRD) Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global End-Stage Renal Disease (ESRD) Drugs Sales by Regions 2015-2020 (K Pcs)
Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2019)
Table 20. End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Price (2015-2020) (USD/Pcs)
Table 23. End-Stage Renal Disease (ESRD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table 25. Date of International Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2015-2020)
Table 29. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2015-2020)
Table 31. End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2021-2026)
Table 33. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 34. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2015-2020)
Table 35. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2021-2026)
Table 36. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Application (2021-2026)
Table 37. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2015-2020) (US$ Million)
Table 38. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) of Key Companies (2015-2020)
Table 40. Japan End-Stage Renal Disease (ESRD) Drugs Sales Share by Company (2015-2020)
Table 41. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2015-2020)
Table 43. Japan End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2015-2020)
Table 44. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan End-Stage Renal Disease (ESRD) Drugs Price (K Pcs) by Type (2015-2020)
Table 46. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2021-2026)
Table 47. Japan End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2021-2026)
Table 48. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2021-2026)
Table 50. Japan End-Stage Renal Disease (ESRD) Drugs Price (K Pcs) by Type (2021-2026)
Table 51. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2015-2020)
Table 52. Japan End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2015-2020)
Table 53. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2021-2026)
Table 55. Japan End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2021-2026)
Table 56. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2021-2026)
Table 58. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 60. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 62. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 63. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 64. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2015-2020)
Table 70. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 78. CTI BioPharma Corp Corporation Information
Table 79. CTI BioPharma Corp Description and Business Overview
Table 80. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product
Table 82. CTI BioPharma Corp Recent Development
Table 83. Merck & Co Inc Corporation Information
Table 84. Merck & Co Inc Description and Business Overview
Table 85. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Merck & Co Inc Product
Table 87. Merck & Co Inc Recent Development
Table 88. Novartis AG Corporation Information
Table 89. Novartis AG Description and Business Overview
Table 90. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Novartis AG Product
Table 92. Novartis AG Recent Development
Table 93. Prolong Pharmaceuticals LLC Corporation Information
Table 94. Prolong Pharmaceuticals LLC Description and Business Overview
Table 95. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Prolong Pharmaceuticals LLC Product
Table 97. Prolong Pharmaceuticals LLC Recent Development
Table 98. VESSL Therapeutics Ltd Corporation Information
Table 99. VESSL Therapeutics Ltd Description and Business Overview
Table 100. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. VESSL Therapeutics Ltd Product
Table 102. VESSL Therapeutics Ltd Recent Development
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key End-Stage Renal Disease (ESRD) Drugs Players
Table 107. End-Stage Renal Disease (ESRD) Drugs Customers List
Table 108. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Product Picture
Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Calcium Succinate Product Picture
Figure 4. Mk-3866 Product Picture
Figure 5. Pacritinib Product Picture
Figure 6. Sanguinate Product Picture
Figure 7. Tesidolumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. ICU
Figure 13. Others
Figure 14. End-Stage Renal Disease (ESRD) Drugs Report Years Considered
Figure 15. Global End-Stage Renal Disease (ESRD) Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global End-Stage Renal Disease (ESRD) Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region in 2019
Figure 20. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region in 2019
Figure 22. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by End-Stage Renal Disease (ESRD) Drugs Revenue in 2019
Figure 24. End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2019
Figure 27. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type in 2019
Figure 29. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Price Range (2015-2020)
Figure 30. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2019
Figure 32. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application in 2019
Figure 34. Japan End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Japan End-Stage Renal Disease (ESRD) Drugs Market Share in Global Market 2015-2026
Figure 37. Japan 5 and 10 Largest End-Stage Renal Disease (ESRD) Drugs Players Market Share by Revenue in End-Stage Renal Disease (ESRD) Drugs in 2019
Figure 38. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2015-2020)
Figure 39. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 40. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2015-2020)
Figure 41. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 45. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 46. U.S. End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 53. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 54. Germany End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region in 2019
Figure 67. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region in 2019
Figure 68. China End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 93. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. End-Stage Renal Disease (ESRD) Drugs Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs